Short-term positive airway pressure therapy response in obstructive sleep apnea patients: Impact of treatment on the quality of life;Obstrüktif uyku apne olgularinda pozitif hava yolu basinci tedavisine erken yanitin deǧerlendirilmesi: Tedavinin yaşam kalitesi üzerine etkisi

Tuberkuloz ve Toraks

Volumn 60, Issue 4, 2012, Pages 327-335

  Yurtlu, Şirin ^a   Sariman, Nesrin ^a   Levent, Ender ^a   Soylu, Akin Cem ^a   Alparslan, Sümeyye ^a   Saygi, Attila ^a  

^a MALTEPE UNIVERSITY   (Turkey)

Author keywords

Compliance; Obstructive sleep apnea syndrome; Positive airway pressure treatment; Sleep apnea quality of life index

Indexed keywords

ADULT; AGED; APNEA HYPOPNEA INDEX; ARTICLE; CLINICAL ARTICLE; DAYTIME SOMNOLENCE; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; MALE; OXYGEN SATURATION; PATIENT ATTITUDE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PULSE OXIMETER; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SLEEP DISORDERED BREATHING;

EID: 84872181587     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: 10.5578/tt.4057     Document Type: Article

References (38)

1. Bollig SM. Encouraging CPAP adherence: it is everyone's job. Respir Care 2010; 55: 1230-6.
2. Giles TL, Lasserson TJ, Smith BH, White J, Wright JJ, Cates CJ. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006; 3: 1;CD001106
3. Olsen S, Smith S, Oei T. Adherence to continuous positive airway pressure therapy in obstructive sleep apnoea sufferers: a theoretical approach to treatment adherence and intervention. Clinical Psychology Review 2008; 28: 1355-71.
4. Shapiro GK, Shapiro CM. Factors that influence CPAP adherence: an overview. Sleep Breath 2010; 14: 323-35.
5. Sanders MH, Gruendl CA, Rogers RM. Patient compliance with nasal CPAP therapy for sleep apnea. Chest 1986; 90: 330-3.
6. Meslier N, Lebrun T, Grillier-Lanoir V, Rolland N, Henderick C, Sailly JC, et al. A French survey of 3.225 patients treated with CPAP for obstructive sleep apnoea: benefits, tolerance, compliance and quality of life. Eur Respir J 1998; 12: 185-92.
7. Flemons WW, Reimer MA. Measurement properties of the Calgary Sleep Apnea Quality of Life Index. Am J Respir Crit Care Med 2002; 165: 159-64.
8. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991; 14: 540-5.
9. Epstein LJ, Kristo D, Strollo PJ, Friedman N, Malhotra A, Patil PS, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2009; 5: 263-76.
10. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep satges in human subjects. CA: Brain Information Service, Los Angeles, UCLA, 1968.
11. st ed. Westchester, IL: American Academy of Sleep Medicine 2007.
12. Mc Ardle N, Douglas NJ. Effect of continuous positive airway pressure on sleep architecture in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001; 164: 1459-63.
13. Sin DD, Mayers I, Man GCW, Ghahary A, Pawluk L. Can positive airway pressure therapy improve the general health status of patients with obstructive sleep apnea? A clinical effectiveness study. Chest 2002; 122: 1679-85.
14. Berg S. Obstructive sleep apnoea syndrome: current status. Clin Respir J 2008; 2: 192-201.
15. Kushida CA, Chediak A, Berry RB, Brown LK, Gozal D, Iber C, et al. Clinical guideliness for the manual titration of positive airway pressure in patients with obstructive sleep apnea. Positive Airway Pressure Titration Task Force of the American Academy of Sleep Medicine Task Force Members. J Clin Sleep Med 2008; 4: 157-71.
16. McArdle N, Devereux G, Heidarnejad H, Engleman HM, Mackay TW, Douglas NJ. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 1108-14.
17. Mc Nicholas WT. Diagnosis of obstructive sleep apnea in adults. Proc Am Thorac Soc 2008; 5: 154-60.
18. Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993; 147: 887-95.
19. Avlonitou E, Kapsimalis F, Varouchakis G, Varvadas CI, Behrakis P. Adherence to CPAP therapy improves quality of life and reduces symptoms among obstructive sleep apnea syndrome patients. Sleep Breath 2012; 16: 563-9.
20. Pieters T, Collard P, Aubert G, Dury M, Delguste P, Rodenstein DO. Acceptance and long-term compliance with nCPAP in patients with obstructive sleep apnoea syndrome. Eur Respir J 1996; 9: 939-44.
21. Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68-73.
22. Mc Nicholas WT, Bonsignore MR. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007; 29: 156-78.
23. Sanner BM, Klewer J, Trumm A, Randerath W, Kreuzer I, Zidek W. Long-term treatment with continuous positive airway pressure improves quality of life in obstructive sleep apnoea syndrome. Eur Respir J 2000; 16: 118-22.
24. Bolitschek J, Schmeiser-Rieder A, Schobersberger R, Rosenberger A, Kunze M, Aigner K. Impact of nasal continuous positive airway pressure treatment on quality of life in patients with obstructive sleep apnoea. Eur Respir J 1998; 11: 890-4.
25. Johns M.W. Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest 1993; 103: 30-6.
26. Mc Nicholas WT. Compliance with nasal CPAP therapy for obstructive sleep apnoea: how much is enough? Eur Respir J 1997; 10: 969-70.
27. Ashtyani H, Hutter DA. Collateral damage: the effects of obstructive sleep apnea on bed partners. Chest 2003; 124: 780-1.
28. Waldhorn RE, Herrick TW, Nguyen MC, O'Donnell AE, Sodero J, Potolicchio SJ. Long-term compliance with nasal continuous positive airway pressure therapy of obstructive sleep apnea. Chest 1990; 97: 33-8.
29. Meurice JC, Dore P, Paquereau J, Neau JP, Ingrand P, Chavagnat JJ, et al. Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome. Chest 1994; 105: 429-33.
30. Engleman HM, Asgari-Jirhandeh N, McLeod AL, Ramsay CF, Deary IJ, Douglas NJ. Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest 1996; 109: 1470-6.
31. Cruz IA, Drummond M, Winck JC. Obstructive sleep apnea symptoms beyond sleepiness and snoring: effects of nasal APAP therapy. Sleep Breath 2012; 16: 361-6.
32. Jennum P. Quality of life, co-morbidity and obstructive sleep apnoea. Clin Respir J 2010; 4: 129-30.
33. MunÄoz A, Mayoralas LR, Barbe F, PericaÂs J, Agustõ AGN. Long-term effects of CPAP on daytime functioning in patients with sleep apnoea syndrome. Eur Respir J 2000; 15: 676-81.
34. Olsen S, Smith S, Oei T, Douglas J. Health belief model predicts adherence to CPAP before experience with CPAP. Eur Respir J 2008; 32: 710-17.
35. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea. Am J Respir Crit Care Med 2002; 165: 1217-39.
36. Fleury B, Rakotonanahary D, Hausser-Hauw C, Lebeau B, Guilleminault C. Objective patient compliance in long-term use of nCPAP. Eur Respir J 1996; 9: 2356-9.
37. Flemons WW, Tsai W. Quality of life consequences of sleep-disordered breathing. J Allergy Clin Immunol 1997; 99: 750-6.
38. Akashiba T, Kawahara S, Akahoshi T, Omori C, Saito O, Majima T, et al. Relationship between quality of life and mood or depression in patients with severe obstructive sleep apnea syndrome. Chest 2002; 122: 861-5.